% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Janisova:449052,
author = {Janisova, Larisa and Gruzinov, Andrey and Zaborova, Olga V.
and Velychkivska, Nadiia and Vaněk, Ondřej and Chytil,
Petr and Etrych, Tomáš and Janoušková, Olga and Zhang,
Xiaohan and Blanchet, Clement and Papadakis, Christine M.
and Svergun, Dmitri I. and Filippov, Sergey K.},
title = {{M}olecular {M}echanisms of the {I}nteractions of
{N}-(2-{H}ydroxypropyl)methacrylamide {C}opolymers
{D}esigned for {C}ancer {T}herapy with {B}lood {P}lasma
{P}roteins},
journal = {Pharmaceutics},
volume = {12},
number = {2},
issn = {1999-4923},
address = {Basel},
publisher = {MDPI},
reportid = {PUBDB-2020-03577},
pages = {1-9},
year = {2020},
abstract = {The binding of plasma proteins to a drug carrier alters the
circulation of nanoparticles (NPs) in the bloodstream, and,
as a consequence, the anticancer efficiency of the entire
nanoparticle drug delivery system. We investigate the
possible interaction and the interaction mechanism of a
polymeric drug delivery system based on
N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers (pHPMA)
with the most abundant proteins in human blood
plasma—namely, human serum albumin (HSA), immunoglobulin G
(IgG), fibrinogen (Fbg), and apolipoprotein (Apo) E4 and
A1—using a combination of small-angle X-ray scattering
(SAXS), analytical ultracentrifugation (AUC), and nuclear
magnetic resonance (NMR). Through rigorous investigation, we
present evidence of weak interactions between proteins and
polymeric nanomedicine. Such interactions do not result in
the formation of the protein corona and do not affect the
efficiency of the drug delivery.},
cin = {EMBL-User / EMBL},
ddc = {610},
cid = {I:(DE-H253)EMBL-User-20120814 / I:(DE-H253)EMBL-20120731},
pnm = {6G3 - PETRA III (POF3-622)},
pid = {G:(DE-HGF)POF3-6G3},
experiment = {EXP:(DE-H253)P-P12-20150101},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32013056},
UT = {WOS:000519268500076},
doi = {10.3390/pharmaceutics12020106},
url = {https://bib-pubdb1.desy.de/record/449052},
}